AC Immune ACIU
NASDAQ ACIU
$2.72 -0.09 (-3.20%)
At close: Oct 2, 2026 · 4:00 PM EDT

AC Immune (ACIU) Return on Equity [ROE] (2016 - 2026)

Updated

AC Immune (ACIU) reported Return on Equity [ROE] of -128.20% for the quarter ended Jun 30, 2026, down 68.49 percentage points from -59.72% a year earlier but up 42.50 percentage points from the prior quarter.

Analysis

AC Immune (ACIU) Return on Equity [ROE] (2016 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, AC Immune posted Return on Equity [ROE] of -93.50%, down 55.73 percentage points from the prior year.

  • Return on Equity [ROE] has a five-year change of -67.30 percentage points (years ended Dec 2020 to Dec 2025).
  • By year, Return on Equity [ROE] came in at -37.77% in the year ended Dec 31, 2024 (-3.85 pp), -33.92% in the year ended Dec 31, 2023 (+0.49 pp), -34.42% in the year ended Dec 31, 2022 (-1.38 pp) and -33.03% in the year ended Dec 31, 2021 (-6.84 pp).
  • Five-year quarterly Return on Equity [ROE] spans a low of -170.70% in the quarter ended Mar 31, 2026 and a high of -31.13% in the quarter ended Sep 30, 2024.
  • Year over year, Return on Equity [ROE] has now declined in each of the last seven quarters, with an average year-over-year change of -44.70 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was the quarter ended Sep 30, 2024 (a gain of 18.84 percentage points); the low point was the quarter ended Mar 31, 2026 (a drop of 121.03 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -170.70% (quarter ended Mar 31, 2026), -126.01% (quarter ended Dec 31, 2025) and -100.53% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 AC Immune 276.74 Mn 276.74 Mn - -128.20%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -128.20%
Mar 31, 2026 -170.70%
Dec 31, 2025 -126.01%
Sep 30, 2025 -100.53%
Jun 30, 2025 -59.72%
Mar 31, 2025 -49.67%
Dec 31, 2024 -41.17%
Sep 30, 2024 -31.13%
Jun 30, 2024 -45.08%
Mar 31, 2024 -35.56%
Dec 31, 2023 -37.20%
Sep 30, 2023 -49.97%
Jun 30, 2023 -44.40%
Mar 31, 2023 -42.72%
Dec 31, 2022 -39.90%
Sep 30, 2022 -38.23%
Jun 30, 2022 -36.71%
Mar 31, 2022 -33.81%
Dec 31, 2021 -35.74%
Sep 30, 2021 -38.89%
API Access

AC Immune Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACIU&period=max&api_key=YOUR_API_KEY